The study assesses the extent to which member countries of the African Regional Intellectual Property Organization (ARIPO) have taken advantage of flexibility in the global trade restrictions in TRIPS to provide medicine for their infected citizens. It draws on interviews with policy makers, manufacturers, and national drug regulatory authorities in Ghana, Kenya, Mozambique, South Africa, and Zimbabwe.
本站所有内容均为互联网搜索引擎提供的公开搜索信息,本站不存储任何数据与内容,任何内容与数据均与本站无关,如有需要请联系相关搜索引擎包括但不限于百度,google,bing,sogou 等
© 2025 onlinetoolsland.com All Rights Reserved. 本本书屋 版权所有